Introduction
Grb7 is an emerging family of adaptor (cytosolic) signaling proteins devoid of intrinsic enzymatic activity, similar to Grb2, Shc, and Nck (Margolis et al., 1992) . Like these other adaptor molecules, Grb7 family proteins have been shown to mediate the coupling of various cell surface receptors with speci®c downstream signaling pathways. Grb7 family proteins, comprising of Grb7, Grb10, and Grb14, share signi®cant sequence homology and a conserved molecular architecture. In this review, we will discuss the structure, biochemical properties and subcellular localization, interactions with other proteins, and physiological functions of the Grb7 family adaptor molecules.
Structure
Grb7 encodes a 535-amino acid protein consisting of several distinctive structural features including an amino-terminal proline-rich region, a central segment termed the GM region (for Grb and Mig), and a carboxyl-terminal src-homology 2 (SH2) domain ( Figure  1 ). Grb7 has ®ve minimal consensus, PXXP motifs, for binding to src-homology 3 (SH3) domain-containing proteins. No proteins have yet been identi®ed to interact with this proline-rich region of Grb7. However, the proline-rich region of Grb10 has been shown to bind the SH3 domain of c-Abl in vitro, although it was unable to interact with the SH3 domain of PI3K, Grb2, or Fyn (Frantz et al., 1997) . More recently, Lyons et al. (2001) identi®ed a novel human Tankyrase, an ankyrin repeatcontaining poly (ADP-ribose) polymerase (PARP), which can interact with Grb14. This interaction is mediated by the N-terminal 110 amino acids of Grb14 and ankyrin repeats 10 ± 19 of Tankyrase 2.
The central GM domain contains a region of *300 amino acids showing high sequence homology (approximately 50% amino acid identity) between the Grb7 family members and a Caenorhabditis elegans gene product, Mig-10 (Manser et al., 1997; Ooi et al., 1995; Stein et al., 1994) . The Mig-10 protein plays a role in long range migration of neuronal cells during embryonic development (Manser and Wood, 1990) . This sequence similarity raises the possibility that Grb7 or other family members may play a role in the regulation of migration of mammalian cells. Indeed, we have recently found that Grb7 can interact with focal adhesion kinase (FAK) and this interaction is critical for mediating FAK-regulated cell migration (Han and Guan, 1999; Han et al., 2000) .
The GM region includes within it a centered pleckstrin homology (PH) domain, a putative RA (Ra1 GDS/AF6 or Ras-Associating) domain amino terminal to the PH domain, and a functional region of about 50 amino acids called BPS (between the PH and SH2 domain) (Manser et al., 1997; Ooi et al., 1995; Wojcik et al., 1999) . The PH domain of Grb7 was ®rst proposed when mGrb10a was cloned and analysed (Ooi et al., 1995) . Recent data from our laboratory con®rms that the PH domain of Grb7 can bind to speci®c phosphoinositides, which required the same critical arginine residue as in other PH domains known to bind phosphoinositides (Shen et al., unpublished data) . The RA domain was proposed in Grb7 family proteins based on sequence analysis (Wojcik et al., 1999) . This suggests the interesting possibility that Grb7 family members might regulate the Ras signaling pathways that are important for cell proliferation. However, several dierent approaches failed to detect Grb7/G-protein interactions (Leavey et al., 1998) . Thus the functional signi®cance of the putative RA domain is not certain. Studies by He et al. (1998) suggest that the dierent sequences of BPS in Grb7 family members might enhance the binding speci®city of these proteins to receptor tyrosine kinases mediated by their SH2 domains. It is not clear whether BPS is an independent-folding unit like the SH2 domain or if it aects binding speci®city through its impact on the structure of the adjacent SH2 domains. In addition, the Grb10 BPS domain recently was shown to interact with the core kinase domain of the insulin and IGF receptors in a phosphorylation-dependent manner (Dong et al., 1998; He et al., 1998) . This may regulate the catalytic activity of the receptors (Stein et al., 2001 ).
The carboxyl SH2 domain has been shown to play an important role in the interaction between Grb7 family proteins and receptor tyrosine kinases and other tyrosine-phosphorylated signaling molecules. The SH2 domain of Grb7 shares about 70% amino acid identity with the SH2 domains of Grb10 and Grb14. However, the dierent family members seem to have dierent preferences for binding partners. For instance, the Grb7 SH2 domain binds to erbB2 strongly, but the Grb14 SH2 domain can not associate with it (Janes et al., 1997) . Similarly, whereas hGrb7 associates with FAK through its SH2 domain (Han and Guan, 1999) , hGrb10g does not bind to FAK (Frantz et al., 1997) . These results suggest that the dierent Grb7 family members have evolved to interact with speci®c functional partners. A novel splice variant of human Grb7, Grb7V, lacks the SH2 domain (i.e. the last 88 bp in the carboxy terminus are truncated). The expression of this variant has been reported to be associated with invasive esophageal carcinoma (Tanaka et al., 1998) . Compared to wild type Grb7, this isoform does not respond to EGF stimulation and is not dephosphorylated in serum-starved quiescent condition presumably due to the lack of the SH2 domain binding to EGFR or PHPTP2. This study highlights the functional importance of the SH2 domain in Grb7 family proteins.
Expression, phosphorylation, and subcellular localization
In mouse, Grb7 is highly expressed in kidney and liver, but is not reported to be expressed in spleen, brain, heart, and lung (Margolis et al., 1992) . Curiously, Grb7's expression pattern in human tissues is dierent. Generally, Grb7 has a broader expression pro®le in human (pancreas4kidney, placenta, prostate, intestine4colon, liver, lung, testis) than in mouse (Frantz et al., 1997) . Grb10 and Grb14 also have broad expression pro®les (Daly et al., 1996; Frantz et al., 1997; Liu and Roth, 1995; O'Neill et al., 1996) . Grb7, Grb10, and Grb14 are most abundantly expressed in pancreas. To date, according to newly adopted nomenclature (Daly, 1998) , there are two splicing variants (hGrb7 and hGrb7V) of Grb7, six variants (mGrb10a, hGrb10b, hGrb10g, mGrb10d, hGrb10e, and hGrb10z) of Grb10, and three variants (hGrb14, mGrb14, and rGrb14) of Grb14.
Grb7 is phosphorylated on serine and threonine residues in both quiescent and growth factor (EGF or heregulin) stimulated cells, and treatment with growth factors does not alter its phosphorylation state (Fiddes et al., 1998; Stein et al., 1994) . In contrast to Grb7, Grb10g has been reported to be serine phosphorylated and this can be stimulated upon insulin treatment (Dong et al., 1997) . mGrb10 is known to be phosphorylated on serine residues after EGF treatment (Ooi et al., 1995) . Similarly, Grb14 is phosphorylated on serine or threonine residues and its phosphorylation is further stimulated by PDGF (Daly et al., 1996) or FGF-2 treatment (Reilly et al., 2000) . Although most The proteins known to interact with speci®c domain of Grb7 family are shown. Tyrosine phosphorylation in GM domain by FAK or other kinases creates binding sites for SH2 domaincontaining signaling proteins. EGFR, Tek, IR, and FAK has been shown to phosphorylate Grb7 family proteins, although the site(s) has not been mapped (broken arrows). Pro, proline-rich region; GM, Grb and Mig-10; SH2, Src homology-2; RA, RasAssociating; PH, pleckstrin homology; BPS, between the PH and SH2; PIPs, phosphatidylinositol phosphates of the Grb7 family members are phosphorylated on serine and/or threonine residues, there is no report for the function of these phosphorylations.
Recently, several laboratories have observed tyrosine phosphorylation of Grb7 Jones et al., 1999; Tanaka et al., 2000) . Jones et al. (1999) ®rst showed that Grb7 binds to Y1100 of Tek receptor tyrosine kinase and mutation of this residue to F abolishes both Grb7 binding and its tyrosine phosphorylation by Tek. Similarly, tyrosine phosphorylation of Grb7 was detected when FAK was activated by replating cells on ®bronectin or FAK was overexpressed . Furthermore, Grb7 phosphorylation is stimulated only by wild-type FAK but not by kinase-defective FAK or by the FAK mutant (Y397 to F) which lacks the binding site for Grb7. In addition, overexpression of FAK increases tyrosine phosphorylation of Grb7 in SYF cells (de®cient for Src, Yes, and Fyn expression). These results suggest that FAK-dependent Grb7 phosphorylation does not require Src family tyrosine kinases. Tanaka et al. (2000) also reported tyrosine phosphorylation of Grb7 in human esophageal carcinoma cells when cells were treated with EGF or when cells were replated on ®bronectin-coated dishes. There are several tyrosines in Grb7. But the phosphorylation sites have yet to be mapped and it is not clear whether the same sites are phosphorylated under these dierent conditions.
Grb10 has also been reported to be tyrosine phosphorylated (Frantz et al., 1997; Langlais et al., 2000; Mano et al., 1998) . When HIRc cells are stimulated with insulin, Grb10 associates with IR in an activation-dependent manner and is transiently tyrosine phosphorylated (Frantz et al., 1997) . Furthermore, tyrosine phosphorylation of Grb10 does not require binding to IR or IR's kinase activity (Langlais et al., 2000) . Instead, inhibition of Src kinase by the chemical inhibitor, herbimycin A, or by expression of a dominant-negative Src blocks Grb10 phosphorylation, suggesting that Grb10 is a substrate of Src family kinase. Another report shows that tyrosine phosphorylation of Grb10 can be stimulated by Tek (Mano et al., 1998) . At present, there are no reports of tyosine phosphorylation of Grb14. However, it is likely that Grb14 can also be tyrosine phosphorylated under appropriate conditions, given its similarity to other Grb7 family members in structure and ability to interact with several tyrosine kinases like FGFR, EGFR, PDGFR, IR, and Tek/Tie2. hGrb7 can be detected in both the cytoplasm and discrete regions of the plasma membrane called focal contacts . Deletion of the SH2 domain of Grb7 abolishes its localization at focal contacts, suggesting that the SH2 domain is important for Grb7 to localize to focal contacts. The PH domain may also contribute to Grb7's localization by targeting it to the plasma membrane through its interaction with phospholipids. This may facilitate Grb7 interaction with FAK in focal contacts. Grb10 was ®rst reported as a soluble protein and localized to the plasma membrane following insulin treatment (Dong et al., 1997; Frantz et al., 1997) . However, when a dierent antibody was used, hGrb10z was found to peripherally associate with mitochondria (Nantel et al., 1999) . After stimulation with serum or growth factor, a small portion of Grb10 localizes at the plasma membrane and in actin-rich membrane rues. Further studies are necessary to ®nd the structural determinants for the dierent localizations reported.
Binding partners
Grb7 was initially identi®ed as an EGF receptor binding protein by using a cloning method called CORT (cloning of receptor targets) (Margolis et al., 1992) . Thereafter, many other binding partners have been reported for Grb7 including HER2/Shc (Stein et al., 1994) , SHPTP2 (Keegan and Cooper, 1996) , Ret (Pandey et al., 1996) , PDGFR (Yokote et al., 1996) , erbB2 receptor (Janes et al., 1997) , erbB3 receptor (Fiddes et al., 1998) , c-Kit (Thommes et al., 1999) , FAK (Han and Guan, 1999) , Tek/Tie2 (Jones et al., 1999) , c-Kit/SCFR (Thommes et al., 1999) , Rnd1 (Vayssiere et al., 2000) , IR (Kasus-Jacobi et al., 2000), caveolin (Lee et al., 2000) . Most, if not all, of these interactions are through the interaction of the SH2 domain of Grb7 with a phosphotyrosine motif in its binding partners in a signal dependent manner. More than 10 dierent binding sites have been mapped so far (Table 1) . However, there is no common consensus sequence for Grb7 binding, suggesting that Grb7 binding to other proteins is highly promiscuous.
Grb10 has also been shown to associate with several proteins including the EGF receptor (Frantz et al., 1997; He et al., 1998; Ooi et al., 1995) , IR (Hansen et al., 1996; Liu and Roth, 1995; Dong et al., 1997; Frantz et al., 1997; O'Neill et al., 1996) , Ret (Pandey et al., 1995) , IGFR (Dey et al., 1996; He et al., 1998; Morrione et al., 1996; O'Neill et al., 1996) , Elk/EphB1 (Stein et al., 1996) , PDGF receptor (Frantz et al., 1997) , Tek/Tie (Mano et al., 1998) , Raf/MEK1 (Nantel et al., 1998) , Nedd4 (Morrione et al., 1999) , BCR-ABL (Bai et al., 1998) , and GH receptor (Moutoussamy et al., 1998) . In contrast, Grb14 has been reported to have fewer binding partners including EGFR/PDGFR (Daly et al., 1996) , IR (Kasus-Jacobi et al., 1998), Tek/ Tie2 (Jones et al., 1999) , FGF receptor (Reilly et al., 2000) . It is likely that additional binding partners will be discovered for Grb7 family proteins given their role as adaptor molecules in signal transduction.
There are also reports suggesting that Grb7 family members may interact with itself or with each other to form homo-or hetero-dimers/oligomers. Grb10 is shown to dimerize/oligomerize through interaction between the N-terminal domain of one molecule and the PH/BPS/SH2 domains of another (Dong et al., 1998) . In addition, Grb10 is reported to bind Grb7 in a yeast two-hybrid assay (unpublished data by J Cooper in Dong et al., 1998) . Furthermore, as described above, Grb7 and Grb10 have multiple variants, making it possible to generate many dierent complexes in cells. This raises a potentially interesting mechanism for Grb7 family proteins to mediate their functions. Each subunit of Grb7/Grb10 complex could bind to a dierent cellular protein and oligomerization would bring these components in one place to coordinate multiple signaling pathways.
Roles in cell proliferation and apoptosis
All Grb7 family members interact with growth factor receptors in an activation dependent manner, suggesting that they might be involved in the regulation of cell proliferation. Several studies suggest a role for Grb10 in cell proliferation. Expression of the SH2 domain of Grb10/IR-SV1 (hGrb10g) inhibits DNA synthesis induced by insulin and IGF-1 (O'Neill et al., 1996) . One report showed that stable overexpression of mGrb10a inhibits IGF-I mediated cell proliferation (Morrione et al., 1997) . In another report, however, it was found that overexpression of the same mGrb10a increased DNA synthesis upon growth factor (PDGF BB, IGF-I, or insulin) treatment whereas expression of its SH2 domain alone decreased cell proliferation (Wang et al., 1999) . Interestingly, the dominant negative eect of the SH2 domain does not require its receptor binding activity. Additional studies are clearly needed to resolve the contradicting roles for mGrb10a shown in these two reports. A number of studies also showed that expression of exogenous Grb14 inhibits DNA synthesis stimulated by insulin, serum or FGF-2 (Kasus-Jacobi et al., 1998; Reilly et al., 2000) . There are no reports which suggest a role for Grb7 in the regulation of cell proliferation. Indeed, our laboratory has shown recently that overexpression of the Grb7 SH2 domain does not decrease cell cycle progression (Reiske et al., 2000) , although it inhibited cell migration under similar conditions (Han and Guan, 1999) . These results suggest that Grb7 family members may play dierent roles in various cellular functions such as cell proliferation and migration.
Grb10 has also been suggested to play a role in the regulation of apoptosis. The SH2 domain of Grb10 was reported to interact with Raf1 and MEK1 in a phosphotyrosine independent manner (Nantel et al., 1998) . Using a random mutagenesis approach, Grb7 family adaptor molecules DC Han et al Nantel et al. (1998) isolated three mutants, Grb10 RL, Grb10 SC, or Grb10 TS that are defective in interaction with EGFR, IR, Raf1, or MEK1 at dierent levels. Expression of these Grb10 mutants induced apotosis in Cos-7 and HTC-IR cells and coexpression of wild type Grb10 can increase cell survival. Interestingly, they also showed that endogenous Grb10 can be localized to mitochondria where it interacted with the anti-apoptotic mitochondrial Raf targeted by Bcl-2 (Nantel et al., 1999; Wang et al., 1996) . The PH domain of Grb10 was proposed to play an important role in targeting it to the mitochondria because a PH domain-deleted hGrb10b only exists in the cytoplasm.
Roles in cell migration
Cell migration is critical for biological processes such as development, immune response, wound healing, and tumor metastasis. Growth factor receptors are important not only for cell proliferation but also for cell migration in response to some of the growth factors or chemoattractants. Many growth factor receptors are known to interact with the Grb7 family proteins (see Table 1 ), suggesting a potential role of Grb7 proteins in mediating signaling in cell migration. In addition, the Grb7 family molecules share sequence homology with Mig-10, a Caenorhabditis elegans, gene which has been implicated in neuronal migration in embryonic development. Recent studies from our laboratory also suggest a role for Grb7 in the signal transduction of integrin-mediated cell migration. We found that the SH2 domain of Grb7 can directly interact with FAK, which is a cytoplasmic tyrosine kinase known to play an important role in integrinmediated signal transduction and cell migration (Guan, 1997 ). Grb7's interaction with FAK is dependent on cell adhesion, and is mediated by the autophosphorylated Y397 of FAK that is required for FAK signaling (Han and Guan, 1999) . Inducible overexpression of Grb7 in NIH3T3 cell enhanced cell migration toward ®bronectin, whereas its SH2 domain inhibited cell migration (Han and Guan, 1999) . Similarly, transient overexpression of Grb7 in CHO cells stimulated cell migration compared with its truncation mutants whose expression actually inhibited cell migration . Grb7/FAK complex formation and its correlation with increased invasion were also reported in esophageal carcinoma cells (Tanaka et al., 2000) . Conversely, expression of an antisense Grb7 RNA lowers endogenous Grb7 protein levels and suppresses the in vitro invasive phenotype of these cells (Tanaka et al., 1998) . These studies suggest a potential role for Grb7 binding to FAK in tumor metastasis. In contrast to Grb7, overexpression of Grb10a, Grb10g, or Grb14 do not stimulate cell migration . Instead, they showed little inhibition compared with vector transfected cells. These results further supported the notion that Grb7 family members might play distinct roles in dierent cellular functions such as cell proliferation and migration.
Potential role in cancer
Grb7 has been shown to be ampli®ed and overexpressed in concert with HER2 in several breast cancer cell lines and in tissue samples from primary human breast cancer (Stein et al., 1994) . The HER2, a member of the EGF receptor family, is known to be ampli®ed and overexpressed in *25% of human breast cancer (Slamon et al., 1989) . Not only are Grb7 and HER2 overexpressed, they also formed a complex in vivo. This implies that Grb7 and HER2 are involved in the same pathway and its signaling might be highly ampli®ed in certain breast cancer. Supporting evidence was reported from a clinical study. Coexpression of Grb7 with Her2 is related signi®cantly to extramucosal tumor invasion and such a relationship was not observed by either Grb7 or Her2 itself (Tanaka et al., 1997) .
Future prospects
The role of Grb7 family molecules as adaptors in signaling pathways has been ®rmly established from numerous studies showing their interactions with cell surface receptors and other signaling molecules (see Table 1 ). Most of these interactions are through the SH2 domain of Grb7 family members and a phosphotyrosine motif in the activated receptors/other signaling molecules. It is likely that these binding partners are upstream regulators for Grb7 family molecules. In contrast, little is known about potential downstream eectors of the Grb7 family proteins. Given their role as adaptor molecules, it is likely that potential downstream eectors will interact with other conserved domains of Grb7 like the Pro-rich region or the GM region. Currently, only two proteins, c-Abl and Tankyrase, are reported to interact with the amino-terminal domain of the Grb7 family. In the case of c-Abl, the pro-rich region of Grb10 was shown to interact with GST-SH3 (c-Abl). Tankyrase associates with the amino-terminal region of Grb14. Surprisingly, there is no report of proteins that interact with the GM domain despite its homology with the C. elegans Mig-10 protein and potential functions in cell migration. Recent studies from our laboratory suggest that tyrosine phosphorylation within the GM domain and the PH domain mediated phosphoinositide-binding may play important roles in the regulation of cell migration (unpublished results). Future studies to identify proteins that interact with the GM region will be important to fully understand the role of Grb7 family proteins as adaptors in signal transduction.
A second area of future interest will be to understand the structural basis of speci®city in signaling among the Grb7 family members. As discussed above, current data suggested that dierent family members may play distinct roles in cell proliferation and cell migration. Future studies will clarify whether these are due the limited number of studies available on some of the family members (e.g. Grb14) or whether they truly perform distinct cellular functions, and if so, the structural basis as well as the dierent binding partners involved for these distinctions.
